Announcement of the Company’s BOD resolved to support the over-allotment for TPEx listing of AP Biosciences, Inc.

Date of occurrence of the event:2026/05/12 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office Reciprocal shareholding ratios: Not applicable Cause of occurrence: To meet the listing requirements of its investee company, AP Biosciences, Inc., the Company will provide existing shares within 15% of the number of shares […]